{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0006-3074",
      "generic_name": "elbasvir and grazoprevir",
      "labeler_name": "Merck Sharp & Dohme LLC",
      "brand_name": "ZEPATIER",
      "active_ingredients": [
        {
          "name": "ELBASVIR",
          "strength": "50 mg/1"
        },
        {
          "name": "GRAZOPREVIR ANHYDROUS",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0006-3074-02",
          "description": "2 DOSE PACK in 1 CARTON (0006-3074-02)  / 14 TABLET, FILM COATED in 1 DOSE PACK (0006-3074-01)",
          "marketing_start_date": "20160128",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Merck Sharp & Dohme LLC"
        ],
        "rxcui": [
          "1734636",
          "1734642"
        ],
        "spl_set_id": [
          "164dc02a-9180-426a-b8b5-04ab39d2bbd4"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191256",
          "N0000190113",
          "N0000182638",
          "N0000182639",
          "N0000190114"
        ],
        "pharm_class_epc": [
          "Hepatitis C Virus NS5A Inhibitor [EPC]",
          "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "HCV NS3/4A Protease Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]"
        ],
        "unii": [
          "632L571YDK",
          "8YE81R1X1J"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "227ae348-5f6f-44d8-a6dc-103e63d28102",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160128",
      "product_id": "0006-3074_227ae348-5f6f-44d8-a6dc-103e63d28102",
      "application_number": "NDA208261",
      "brand_name_base": "ZEPATIER",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "HCV NS3/4A Protease Inhibitors [MoA]",
        "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]",
        "Hepatitis C Virus NS5A Inhibitor [EPC]"
      ]
    }
  ]
}